MASHINIi

Kindly MD, Inc..

NAKA.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Kindly MD, Inc. focuses on developing and marketing pharmaceutical products. While specific details about their product pipeline and therapeutic areas are not available in this brief description, the core business revolves around the creation and commercialization of pharmaceuticals. This includes r...Show More

Ethical Profile

Mixed.

Kindly MD, Inc. focuses on providing integrated healthcare services, including chronic pain management and addiction therapy, which critics acknowledge supports "Better Health for All." However, the company faces scrutiny regarding its "Fair Pay & Worker Respect" practices. In 2023, reports indicate the CEO earned $364,523, while the median employee received $61,856, a 6:1 pay ratio. Allegedly, the CEO's compensation increased despite the company remaining unprofitable. Employee feedback on Glassdoor is mixed, with some reviews pointing to management issues and understaffing. The company's data collection activities, while potentially aiding research, also raise concerns about data privacy.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect40
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Kindly MD, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Kindly MD, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

40

In 2023, the CEO to median employee pay ratio was 6:1, with the CEO receiving $364,523 and the median employee earning $61,856.

1

Fair Trade & Ethical Sourcing

0

No evidence was found in the provided articles to assess Kindly MD, Inc. against any of the Fair Trade & Ethical Sourcing KPIs. The articles are primarily SEC filings and business updates, which do not contain information regarding fair trade certifications, supply chain audits, forced/child labor incidents, traceability, remediation speed, ethical clauses in contracts, materials risk, or supplier diversity spend.

1

Honest & Fair Business

0

No evidence available to assess Kindly MD, Inc. on Honest & Fair Business.

Kind to Animals

0

No evidence available to assess Kindly MD, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess Kindly MD, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No specific, quantitative data points related to Planet-Friendly Business metrics for Kindly MD, Inc. (NAKA.US) were found in the provided articles. The articles describe the company's healthcare services, an EPA document on Environmental Impact Assessments for activities in Antarctica, a general overview of the NEPA review process, and details of a securities offering. None of these sources contain information on carbon emissions, renewable energy use, water consumption, waste diversion, green building certifications, climate targets, or any other environmental performance indicators for NAKA.US.

Respect for Cultures & Communities

0

No evidence available to assess Kindly MD, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No specific, concrete evidence was found in the provided articles to assess NAKA.US (Kindly MD, Inc.), a pharmaceutical company, against any of the 'Safe & Smart Tech' KPIs. The articles either discuss general industry trends in healthcare data breaches, refer to a different entity or individual named NAKA (an IT services company, a Russian neural network, or a game creator), or provide a cookie policy for Kindly.ai, none of which are directly attributable to NAKA.US (Kindly MD, Inc.). Therefore, all KPIs are omitted due to lack of relevant data.

Zero Waste & Sustainable Products

0

No specific, quantitative evidence regarding NAKA.US's performance on waste reduction, sustainable products, or related initiatives was found in the provided articles. The articles discuss general market trends in sustainable packaging, regulatory landscapes, and the broader challenges and benefits of recycling in the US, but do not offer any data points directly attributable to NAKA.US for any of the defined KPIs.

Own Kindly MD, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.